Revolutionary & convenient drug delivery platform for fertility/pregnancy, a healthy vaginal microbiome, and other gynaecological conditions
Calla Lily Clinical Care has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in April 2025.
Calla Lily Clinical Care's investors include Innovate UK, National Institute for Health and Care Research, Springboard Enterprises, Embryo Ventures.
Calla Lily Clinical Care is headquartered in London, United Kingdom.
Revolutionary & convenient drug delivery platform for fertility/pregnancy, a healthy vaginal microbiome, and other gynaecological conditions
Calla Lily Clinical Care is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Calla Lily Clinical Care — Funding & Investors." VCBacked, April 3, 2025, https://www.vcbacked.co/company/calla-lily-clinical-care. Accessed August 15, 2026.
VCBacked. (2025). Calla Lily Clinical Care — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/calla-lily-clinical-care
{{cite web |title=Calla Lily Clinical Care — Funding & Investors |url=https://www.vcbacked.co/company/calla-lily-clinical-care |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated